Septerna Inc
NASDAQ: SEPN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Jeffrey T. Finer
- Employees
- 130
- Headquarters
- South San Francisco, United States
- IPO year
- 2024
- Market cap
- $1.6B
- Website
- https://septerna.com
Loading SEPN…
Loading profile data…Frequently asked questions about SEPN
What does Septerna Inc (SEPN) do?
Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases. It develops PTH1R Program, oral small molecule Parathyroid Hormone 1 Receptor agonists for the treatment of hypopara...
Where does SEPN trade?
Septerna Inc (SEPN) trades on the NASDAQ.
What sector is SEPN in?
Septerna Inc (SEPN) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Septerna Inc?
Jeffrey T. Finer is the chief executive officer of Septerna Inc (SEPN).
Where is Septerna Inc headquartered?
Septerna Inc is headquartered in United States.
Does SEPN pay a dividend?
Septerna Inc (SEPN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SEPN go public?
Septerna Inc (SEPN) completed its initial public offering in 2024.